Non-Smokers Urged to Undergo Regular Screening

Rising Concern: 1 in 4 Lung Cancer Cases in India Occur Among Non-Smokers, Say Doctors

BENGALURU | August 1, 2025: Lung cancer is no longer a disease confined to smokers. Up to 25% of lung cancer cases in India are now being reported in individuals who have never smoked, and some Indian studies estimate this number could be as high as 40%. Medical experts point to second-hand smoke, indoor air pollution, occupational hazards, and hormonal factors as key contributors.

Speaking on the occasion of Lung Cancer Day, Dr. Radheshyam Naik, Head of Medical Oncology, Hematology & Bone Marrow Transplantation at Sammprada Hospital, Bengaluru, highlighted the growing burden of lung cancer in Indian metros. “Over the past three decades, we’ve seen a steady rise in lung cancer cases across cities like Delhi, Bengaluru, and Chennai — affecting both men and women. Factors such as smoking, worsening air pollution, and improved awareness leading to early detection have contributed to this trend,” he said.

Dr. Naik emphasized that exposure to carcinogens through second-hand smoke, indoor pollutants from the burning of solid fuels (wood, charcoal, cow dung), and occupational environments are major risks for non-smokers. “India ranks fifth globally for air pollution. Nearly half of Indian adults are routinely exposed to second-hand smoke at home, workplaces, or during commutes. Indoor air pollution alone accounts for 4–6% of the country’s lung cancer burden. Alarmingly, 75% of Indian households still rely on solid fuels for cooking,” he noted.

He further added that long-term exposure to incense smoke in poorly ventilated indoor spaces also poses a significant risk. “People who have burned incense indoors for over 40 years face a fourfold higher risk of lung cancer compared to other non-smokers,” he said.

Dr. Vinod K Ramani, Consultant – Preventive Oncology at Sammprada Hospital, explained that both smokers and non-smokers in India are often diagnosed at advanced stages of lung cancer due to overlapping symptoms with tuberculosis. “Persistent cough, chest pain, and weight loss are common to both TB and lung cancer, often leading to misdiagnosis and delayed treatment — particularly in early-stage cases,” he said.

Treatment options for lung cancer today include immunotherapy, targeted therapy, and post-surgical cancer vaccines aimed at preventing recurrence. Dr. Ramani advised that family members of cancer patients should consider themselves at elevated risk and watch for warning signs such as chronic cough, blood in sputum, or unexplained weight loss. “Non-smokers should undergo regular screenings. A full-body MRI every three years is a good preventive step,” he added.

Offering preventive advice, Dr. Vishwajeeth Pai, Consultant – Medical Oncology at Sammprada Hospital, said individuals should wear pollution masks when outdoors in poor air conditions and avoid inhaling emissions from fossil fuels. “Using LPG for cooking rather than for driving vehicles can reduce indoor pollution. Also, homes should be tested for radon gas, a naturally occurring radioactive substance that seeps from underground soil and can significantly raise lung cancer risk,” he cautioned.

With environmental and lifestyle-related factors increasingly contributing to lung cancer, especially among non-smokers, doctors stressed the urgent need for awareness, timely screening, and clean air practices to tackle this growing public health challenge.

City Today News 9341997936

Apollo Launches ‘CanWin’—A First-of-Its-Kind Cancer Support Community

Apollo Cancer Centres Launches ‘CanWin’ Support Group for Cancer Survivors and Caregivers

Bengaluru, June 25:
Apollo Cancer Centres (ACCs) marked National Cancer Survivors Month with the launch of ‘CanWin’, a dedicated support group aimed at uniting cancer patients, survivors, caregivers, and medical professionals through a shared platform for healing and emotional resilience.

The initiative was introduced at a special event in Bengaluru that featured cancer survivors sharing powerful personal stories under the theme ‘Stories from the STAGE by Cancer Winners’. The storytelling session showcased real-life accounts of perseverance and recovery, underscoring the importance of psychological support in cancer care.

Described as a brand-agnostic platform, CanWin is open to individuals from all backgrounds, irrespective of their treatment provider. The group seeks to create a safe space for open dialogue, mutual encouragement, and collective strength throughout the cancer journey—be it diagnosis, treatment, or survivorship.

Speaking at the event, several survivors from Bengaluru shared how the battle against cancer reshaped their outlook on life. “It wasn’t just about defeating an illness,” said one participant. “It was about discovering strength, building community, and finding purpose in each moment.”

Mr. Dinesh Madhavan, President, Group Oncology & International at Apollo Hospitals, emphasized that cancer care must evolve beyond clinical treatment.
“Medical innovation is only one part of the journey. Emotional connection and community support are equally vital. CanWin creates an ecosystem where survivors and caregivers can draw strength from shared stories and experiences.”

Dr. Preetham Kabbinahithlu, Joint Director, Clinical Administration at Apollo Cancer Centre, Bengaluru, echoed this sentiment.
“Healing is holistic. Through CanWin, we are fostering a culture of empathy, where patients and their loved ones are not alone. It’s a platform that listens, supports, and uplifts.”

The event also featured contributions from professional storytellers who mentored survivors in presenting their experiences as tools for healing and advocacy. Mr. Prashant Pradhan, a storyteller who trained participants, noted,
Oncologists at the event highlighted that cancer survival rates are improving steadily due to early detection, advanced treatment methods, and growing awareness. They stressed that emotional and psychological support plays a crucial role in ensuring quality of life for both patients and survivors.

Going forward, CanWin will organize monthly support sessions, storytelling circles, workshops led by survivors, expert talks, and volunteering opportunities to build a strong and empathetic community.

City Today News 9341997936

Acute Myeloid Leukemia on the Rise: India Faces Urgent Health Crisis

Experts Call for National Action Plan as Delayed Diagnosis and High Costs Take Toll

Bengaluru: As cancer rates continue to climb in India, medical experts are sounding the alarm on Acute Myeloid Leukemia (AML)—a rare but aggressive form of blood cancer that remains underdiagnosed and poorly treated in the country. With a 1–2% rise in all cancers, including hematologic malignancies, specialists warn that India is in a race against time to improve AML detection, access, and treatment.

Silent Killer with a Narrow Window for Survival

AML progresses rapidly and can become fatal within weeks if not caught early. Yet, due to vague symptoms, poor awareness, and limited diagnostic infrastructure, many patients are diagnosed at an advanced stage—when treatment becomes less effective.

“With improved registries and urban detection, we’ve seen a rise in blood cancers, especially in those above 40,” said Dr. Sharat Damodar, Chief of Hematology and Transplant Services at Mazumdar Shaw Medical Center and Narayana Multispeciality Hospital. “Yet fewer than 20% of AML patients undergo essential molecular testing due to cost and lack of insurance coverage.”



Bengaluru Hosts Crucial AML Dialogue

As part of a nationwide series, AbbVie Healthcare held an AML awareness event in Bengaluru, gathering leading oncologists to discuss city-specific challenges and systemic gaps in India’s leukemia care landscape.

Treatment Breakthroughs Remain Out of Reach for Most Indians

Although global advances in precision medicine and targeted therapies have improved AML outcomes—reducing toxicity and boosting survival—Indian patients continue to be left behind. These treatments remain largely confined to private hospitals and are prohibitively expensive for the average citizen.

“We’re seeing remarkable results with targeted therapies abroad,” said Dr. Prasad Narayanan, Director of Medical Oncology at Cytecare Cancer Hospitals. “But in India, lack of policy support and limited access mean most patients never get that chance.”



Experts Propose 6-Point National Strategy to Combat AML

To bridge these gaps, leading hematologists and policy advocates are urging the Indian government to adopt a multi-pronged national strategy, including:

1. Declare AML a Public Health Priority: Enable funding, tracking, and research.


2. Expand Molecular Diagnostic Infrastructure: Bring advanced testing to government and rural hospitals.


3. List AML Drugs in National Cancer Registry: Improve affordability through public schemes and procurement.


4. Reform Insurance Coverage: Include AML therapies under Ayushman Bharat and private health plans.


5. Launch Awareness & Screening Campaigns: Educate public and train general physicians for early detection.


6. Integrate AML into National Health Records: Strengthen data tracking for policy planning and care coordination.



The Time to Act is Now

With the AML burden steadily rising, the window for reform is closing. Experts emphasize that without urgent policy changes, countless lives could be lost to a disease that is increasingly treatable—with the right tools.

“India cannot afford to let AML remain in the shadows,” Dr. Damodar said. “With focused reforms and equitable access, we can change the trajectory for thousands of patients.”

City Today News 9341997936

Apollo Cancer Centres Launch ‘ColFit’ to Combat Rising Colorectal Cancer in India

Bengaluru, April 29, 2025 — Apollo Cancer Centres has unveiled ColFit, a comprehensive colorectal cancer (CRC) screening program aimed at tackling the alarming rise of CRC cases in India, especially among younger populations. The initiative, launched at Apollo Cancer Centre, Bengaluru, focuses on early detection, preventive care, and accessible screening methods to improve survival outcomes and reduce treatment costs.



Why ColFit? The Need for Early Detection in India

Colorectal cancer is among the most preventable and treatable cancers—when caught early. However, in India, most CRC cases are diagnosed at advanced stages, contributing to a five-year survival rate below 40%, among the lowest globally.

ColFit aims to address this crisis by integrating the Faecal Immunochemical Test (FIT)—a non-invasive, accurate screening tool capable of detecting hidden blood in stool, an early sign of CRC. FIT offers high sensitivity, requires only one sample, and does not involve any dietary restrictions.

How ColFit Works: A 3-Step Screening Process

1. Registration and Risk Stratification

Average-risk individuals (45+ with no family history): Recommended for FIT screening.

High-risk individuals (with family history, IBD, or genetic syndromes): Advised to undergo FIT plus colonoscopy.


2. Analysis and Diagnosis

Abnormal FIT results lead to further analysis, including DNA mutation tests and colonoscopies to detect polyps or tumors.


3. Follow-Up and Lifestyle Counselling

Negative results prompt routine follow-ups every 1–10 years.

Positive cases receive further evaluation, biopsies if needed, and personalized lifestyle and screening plans, including genetic counselling.



Expert Insights: Prevention Through Proactivity

“We must shift from reactive care to proactive screening. Lifestyle factors like poor diet, inactivity, and obesity are fueling CRC cases,”
said Dr. Yeshwanth I., Consultant – Surgical Oncology, Apollo Cancer Centre.



He emphasized that early detection could help patients avoid chemotherapy and radiation altogether, particularly in stage 1 or 2 cancers, which can often be treated with surgery alone.

Apollo’s use of Da Vinci robotic systems allows for minimally invasive surgeries, ensuring faster recovery and shorter hospital stays.

“Colorectal cancer is now affecting both young and elderly Indians. Around 60% of cases are caught late, and 20% already have metastases at diagnosis,”
added Dr. Sachin S. Shetty, Senior Consultant – Gastroenterology, Apollo Hospitals, Bannerghatta Road.



ColFit: A Community-Centric Approach to Cancer Care

“ColFit represents Apollo’s commitment to transforming cancer care through innovation and accessibility,”
said Mr. Dinesh Madhavan, President – Group Oncology & International, Apollo Hospitals.



The program is designed not just as a diagnostic tool, but as a public health intervention—empowering individuals to take control of their health through simple, regular screening.



Know the Symptoms and Act Early

Common early symptoms of CRC include:

Persistent changes in bowel habits (constipation or diarrhea)

Rectal bleeding or blood in stool

Unexplained weight loss

Abdominal pain or cramps


Key risk factors: Low-fiber diet, obesity, sedentary lifestyle, smoking, family history, and genetic predisposition.



Take Action Today

Apollo Cancer Centres encourages everyone—especially those with symptoms or family history—to:

Get routine FIT screenings

Consider a colonoscopy if high-risk

Adopt a healthier lifestyle with a high-fiber diet and regular exercise


ColFit is now available at Apollo Cancer Centres across India. Early detection can save lives.



For more information or to book a screening, visit Apollo Cancer Centres Website

City Today News 9341997936

COLOCON-2025 ಭಾರತದಲ್ಲಿ ಕೊಲೊನ್ ಕ್ಯಾನ್ಸರ್ ಕೇರ್ ಅನ್ನು ಮುನ್ನಡೆಸುತ್ತದೆ

ಬೆಂಗಳೂರು, ಜನವರಿ 2025: COLOCON-2025, ಪ್ರವರ್ತಕ CME ಕಾರ್ಯಕ್ರಮವು ಬೆಂಗಳೂರಿನ ಗ್ರೀನ್ ಪಾರ್ಕ್ ಹೋಟೆಲ್‌ನಲ್ಲಿ 200 ಶಸ್ತ್ರಚಿಕಿತ್ಸಕರು ಮತ್ತು ಸ್ನಾತಕೋತ್ತರ ವಿದ್ಯಾರ್ಥಿಗಳು ಭಾಗವಹಿಸುವುದರೊಂದಿಗೆ ಯಶಸ್ವಿಯಾಗಿ ಮುಕ್ತಾಯಗೊಂಡಿತು.  ಡಾ. ಸಂದೀಪ್ ನಾಯಕ್ ಮತ್ತು ತಂಡದ ನೇತೃತ್ವದಲ್ಲಿ, ಈವೆಂಟ್ ಕೊಲೊನ್ ಕ್ಯಾನ್ಸರ್ ಆರೈಕೆಯನ್ನು ಹೆಚ್ಚಿಸಲು ಲ್ಯಾಪರೊಸ್ಕೋಪಿಕ್ ಮತ್ತು ರೊಬೊಟಿಕ್ ಶಸ್ತ್ರಚಿಕಿತ್ಸೆಯಂತಹ ಕನಿಷ್ಠ ಆಕ್ರಮಣಶೀಲ ತಂತ್ರಗಳ ಮೇಲೆ ಕೇಂದ್ರೀಕರಿಸಿತು.

IASO, ಬೆಂಗಳೂರು ಆಂಕೊಲಾಜಿ ಗ್ರೂಪ್, ಸಮ್ರೋಹನಾ ಕ್ಯಾನ್ಸರ್ ಫೌಂಡೇಶನ್ ಮತ್ತು ಫೋರ್ಟಿಸ್ ಆಸ್ಪತ್ರೆಯ ಸಹಯೋಗದೊಂದಿಗೆ, ಕಾರ್ಯಕ್ರಮವು ಪರಿಣಿತ ಸೆಷನ್‌ಗಳು ಮತ್ತು ಪ್ರಾಯೋಗಿಕ ಕಾರ್ಯಾಗಾರಗಳನ್ನು ಒಳಗೊಂಡಿತ್ತು, ಜಾಗತಿಕ ಉತ್ತಮ ಅಭ್ಯಾಸಗಳನ್ನು ಅಳವಡಿಸಿಕೊಳ್ಳಲು ಶಸ್ತ್ರಚಿಕಿತ್ಸಕರಿಗೆ ಅಧಿಕಾರ ನೀಡಿತು.  ಭಾರತದಲ್ಲಿ ಕ್ಯಾನ್ಸರ್ ಆರೈಕೆಯನ್ನು ಪರಿವರ್ತಿಸುವ ನಿಟ್ಟಿನಲ್ಲಿ ಇದೊಂದು ಪ್ರಮುಖ ಹೆಜ್ಜೆ ಎಂದು ಡಾ.ನಾಯಕ್ ಕರೆದರು.

City Today News 9341997936